Silva, Juliana Almeida da 
; Almada, Rafael Carvalho ; Paiva, Yara Bezerra de ; Coimbra, Norberto Cysne
Fonte: Journal of Neural Transmission. Unidade: FMRP
Assuntos: MEDO, PÂNICO, NEURÔNIOS, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juliana Almeida da et al. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity. Journal of Neural Transmission, v. 127, n. 8, p. 1199-1208, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00702-020-02217-8. Acesso em: 06 jul. 2024.APA
Silva, J. A. da, Almada, R. C., Paiva, Y. B. de, & Coimbra, N. C. (2020). Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity. Journal of Neural Transmission, 127( 8), 1199-1208. doi:10.1007/s00702-020-02217-8NLM
Silva JA da, Almada RC, Paiva YB de, Coimbra NC. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity [Internet]. Journal of Neural Transmission. 2020 ; 127( 8): 1199-1208.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s00702-020-02217-8Vancouver
Silva JA da, Almada RC, Paiva YB de, Coimbra NC. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity [Internet]. Journal of Neural Transmission. 2020 ; 127( 8): 1199-1208.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s00702-020-02217-8
